Skip to main content

Retrospective single-center study of endogenous endophthalmitis, Northeastern China, 2010-2023

Journal
Frontiers in cellular and infection microbiology (Q1)
Published
3 September 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Deng Zhang, Feng Gu, Xiaoyu Zhang, Xifan Zhang, Sufei Tian, Baiyi Chen, et al.
PMID
42755882
DOI
10.3389/fcimb.2026.1805346

Why clinicians should know about it

  • Picked for Ophthalmology (paper of the day, 21 September 2026): Intravitreal injection reduces risk of poor visual prognosis

Abstract

OBJECTIVE: To explore the epidemiological characteristics of EnE and the molecular traits of the Klebsiella pneumoniae(KP). METHODS: We revived 40 strains of the KP, utilized whole-genome sequencing technology to understand their molecular epidemiological characteristics. RESULTS: Among 103 EnE patients (69.90% male, 56.31% left eye), vision loss was the chief complaint (96.12%). Extraocular infections were present in 63.11% of patients, most commonly liver abscess (45.00%). KP comprised 81.82% of culture-positive cases. Among 40 KP strains analyzed, 82.5% were hypervirulent KP (hvKP). Phylogenetic analysis revealed the dominance of ST23-K1 lineages. Intravitreal injection was associated with a significantly reduced risk of poor visual prognosis (RR = 0.061, 95%CI: 0.005-0.442) and emerged as an independent protective factor. CONCLUSIONS: The incidence of EnE showed an increasing trend, primarily driven by hvKP ST23-K1. A comprehensive search for systemic infection foci, particularly liver abscesses, is essential. A negative string test result does not exclude hvKP. Timely intravitreal antimicrobial injection is a critical modifiable factor for improving visual prognosis.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.